Latest US Food and Drug Administration Stories
Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc.
Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc.
LISBON, Portugal, July 31, 2014 /PRNewswire/ -- Hovione today announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by the US
DUBLIN, July 18, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
FREDERICK, Md., July 16, 2014 /PRNewswire/ -- ImQuest Pharmaceuticals was recently notified by the US Food and Drug Administration of the approval of its Investigational New Drug (IND) application
Cell-culture technology is a modern alternative to manufacture influenza vaccines without chicken eggs, with potential to rapidly respond to a pandemic BASEL, Switzerland, June 16, 2014
WASHINGTON, May 1, 2014 /PRNewswire/ -- The US Drug Watchdog is now suggesting recipients of an all metal hip implant check out the UK's University of Newcastle's web site about updated
Legacy® Presses for Consistency in Restrictions on Combusted and Non-combusted Products, Especially as They Relate to Candy Flavorings and Advertising Appealing to Youth WASHINGTON,
- Timely collaborations underscore ViiV Healthcare's commitment to increase access to life-saving HIV medicines for children and adults in the developing world LONDON, April 1, 2014 /PRNewswire/
Today marked the official inauguration of its expanded state-of-the-art laboratory and administrative facility in Shanghai, China. Shanghai (PRWEB) January 11,
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.